AIM: To investigate the mechanisms of sulfasalazine (SASP) in the treatment of ulcerative colitis (UC). METHODS: Changes of pathological signs and histological grading of 106 patients with active UC were observed before and after the treatment with SASP, 1 g, thrice daily for 6 wk. RESULTS: The effect of SASP on the vasculitis in lamina propria was 48.2 % and 17.4 % in the mild active UC (P<0.001) and 68 % and 26.7 % in the moderate active UC (P<0.001) before and after treatment. Fibroid necrosis of vessel wall was found in one case of mild UC and two cases of moderate UC before treatment and was not found after treatment. No thrombosis was found in mild UC before and after treatment, while thrombosis was foun
The mode of action of sulphasalazine (SASP) and balsalazide (BSZ), therapeutic agents of inflammator...
Sulfasalazine consists of sulfapyridine and 5-aminosalicylic acid moieties linked by an azo bond. It...
OBJECTIVE: Balsalazide is a novel azo-bonded 5-aminosal-icylic acid treatment for mild-to-moderate u...
The treatment of ulcerative colitis (UC) has changed over the last decade. It is extremely important...
Sulfasalazine is a drug which is useful in the treatment of ulcerative colitis and is also a member ...
目的:评价低剂量柳氮磺吡啶(SASP)联合金双歧治疗溃疡性结肠炎的疗效和安全性.方法:低剂量SASP(1 g/次,3次/d)联合金双歧治疗61例轻中型溃疡性结肠炎患者.结果:55例患者完成了整个疗程,...
Objective: This study targets the inhibition of inflammatory mediators and the enhancement of gastro...
BACKGROUND/AIMS: Clinical outcomes and factors predictive of favorable response after 5-aminosalicyl...
Olsalazine (azodisalicylate) is a new drug in which two molecules of 5-aminosalicylic acid are linke...
Delivery of 5-aminosalicylic acid to the colon by sulphasalazine, other azo-bonded compounds and con...
The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5-ASA) and sulf...
Adipose derived mesenchymal stem cells (ASCs) transplantation is a novel immunomodulatory therapeuti...
During the past 2 ½ years 52 patients with chronic ulcerative colitis were treated with oral salicyl...
Background and aim: Oral mesalazine and sulfasalazine (SASP) are key drugs for treating ulcerative c...
This article reviews the clinical pharmacology, adverse events, and comparative tolerability of the ...
The mode of action of sulphasalazine (SASP) and balsalazide (BSZ), therapeutic agents of inflammator...
Sulfasalazine consists of sulfapyridine and 5-aminosalicylic acid moieties linked by an azo bond. It...
OBJECTIVE: Balsalazide is a novel azo-bonded 5-aminosal-icylic acid treatment for mild-to-moderate u...
The treatment of ulcerative colitis (UC) has changed over the last decade. It is extremely important...
Sulfasalazine is a drug which is useful in the treatment of ulcerative colitis and is also a member ...
目的:评价低剂量柳氮磺吡啶(SASP)联合金双歧治疗溃疡性结肠炎的疗效和安全性.方法:低剂量SASP(1 g/次,3次/d)联合金双歧治疗61例轻中型溃疡性结肠炎患者.结果:55例患者完成了整个疗程,...
Objective: This study targets the inhibition of inflammatory mediators and the enhancement of gastro...
BACKGROUND/AIMS: Clinical outcomes and factors predictive of favorable response after 5-aminosalicyl...
Olsalazine (azodisalicylate) is a new drug in which two molecules of 5-aminosalicylic acid are linke...
Delivery of 5-aminosalicylic acid to the colon by sulphasalazine, other azo-bonded compounds and con...
The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5-ASA) and sulf...
Adipose derived mesenchymal stem cells (ASCs) transplantation is a novel immunomodulatory therapeuti...
During the past 2 ½ years 52 patients with chronic ulcerative colitis were treated with oral salicyl...
Background and aim: Oral mesalazine and sulfasalazine (SASP) are key drugs for treating ulcerative c...
This article reviews the clinical pharmacology, adverse events, and comparative tolerability of the ...
The mode of action of sulphasalazine (SASP) and balsalazide (BSZ), therapeutic agents of inflammator...
Sulfasalazine consists of sulfapyridine and 5-aminosalicylic acid moieties linked by an azo bond. It...
OBJECTIVE: Balsalazide is a novel azo-bonded 5-aminosal-icylic acid treatment for mild-to-moderate u...